Clinical sequelae of hepatitis C acquired from injection drug use

Western Journal of Medicine

Volumn 164, Issue 5, 1996, Pages 399-404

  Tong, Myron J ^a   El Farra, Neveen S ^a  

^a HUNTINGTON MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC ACTIVE HEPATITIS; CHRONIC HEPATITIS; CLINICAL FEATURE; DISEASE COURSE; FATIGUE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMEGALY; HISTOLOGY; HUMAN; INTRAVENOUS DRUG ABUSE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE;

ADULT; AGE DISTRIBUTION; AGED; COHORT STUDIES; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; SURVIVAL RATE;

EID: 0029885284     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Kelen GD, Green GB, Purcell RH, et al: Hepatitis B and hepatitis C in emergency department patients. N Engl J Med 1992; 326:1399-1404
2. Zeldis JB, Jain S, Kuramoto IK, et al: Seroepidemiology of viral infections among intravenous drug users in northern California. West J Med 1992; 156: 30-35
3. Esteban JI, Esteban R, Viladomiu L, et al: Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; 2:294-297
4. Mortimer PP, Cohen BJ, Litton PA. et al: Hepatitis C virus antibody (Letter). Lancet 1989; 2:798
5. Bell J, Batey RG, Farrell GC, Crewe EB, Cunningham AL, Byth K: Hepatitis C virus in intravenous drug users. Med J Aust 1990; 153:274-276
6. van den Hoek JAR, van Haastrecht HJA, Goudsmit J, de Wolf F, Coutinho RA: Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam. J Infect Dis 1990; 162:823-826
7. Alter MJ: The detection, transmission, and outcome of hepatitis C virus infection. Infect Agents Dis 1993; 2:155-166
8. Mattsson L, Weiland O, Glaumann H: Chronic non-A, non-B hepatitis developed after transfusions, illicit self-injections or sporadically - Outcome during long-term follow-up: a comparison. Liver 1989; 9:120-127
9. Gordon SC, Elloway RS, Long JC, Dmuchowski CF: The pathology of hepatitis C as a function of mode of transmission: Blood transfusion vs. intravenous drug use. Hepatology 1993; 18:1338-1343
10. Koretz RL, Abbey H, Coleman E, Gitnick G: Non-A non-B post-transfusion hepatitis - Looking back in the second decade. Ann Intern Med 1993; 119:110-115
11. Seeff LB, Buskell-Bales Z, Wright EC, et al: Long-term mortality after transfusion-associated non-A non-B hepatitis - The National Heart, Lung, and Blood Institute Study Group. N Engl J Med 1992; 327:1906-1911
12. Tong MJ, El-Farra NS, Reikes AR, Co RL: Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332:1463-1466
13. Boyer JL: Chronic hepatitis - A perspective on classification and determinants of prognosis. Gastroenterology 1976; 70:1161-1171
14. Ludwig J: The nomenclature of chronic active hepatitis: An obituary. Gastroenterology 1993; 105:274-278
15. Tong MJ, Lee SY, Hwang SJ, et al: Evidence for hepatitis C viral infection in patients with primary hepatocellular carcinoma. West J Med 1994; 160:133-138
16. Caldwell SH, Li X, Rourk RM, et al: Hepatitis C infection by polymerase chain reaction in alcoholics: False-positive ELISA results and the influence of infection on a clinical prognostic score. Am J Gastroenterol 1993; 88:1016-1021
17. Chien DY, Choo QL, Tabrizi A, et al: Use of recombinant HCV antigen in the serodiagnosis of hepatitis C virus infection: Significant improvement in HCV antibody detection as compared with the first generation HCV C100-3 ELISA and the synthetic peptide EIA tests. J Gastroenterol Hepatol 1993; 8:S33-S39
18. Donahue JG, Nelson KE, Muñoz A, et al: Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. Am J Epidemiol 1991; 134:1206-1211
19. Kiyosawa K, Sodeyama T, Tanaka E, et al: Interrelationship of blood transfusion, non-A non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12(pt 1):671-675
20. Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T: Natural course of chronic hepatitis C. Am J Gastroenterol 1993; 88:240-243
21. Dusheiko G, Schmilovitz-Weiss H, Brown D, et al: Hepatitis C virus genotypes: An investigation of type-specific differences in geographic origin and disease. Hepatology 1994; 19:13-18
22. Mita E, Hayashi N, Kanazawa Y, et al: Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease. J Hepatol 1994; 21:468-473
23. Nousbaum JB, Pol S, Nalpas B, et al: Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995; 122:161-168
24. Simmonds P, Zhang LQ, Watson HG, et al: Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users. Lancet 1990; 336:1469-1472
25. Silini E, Bono F, Cividini A, et al: Molecular epidemiology of hepatitis C virus infection among intravenous drug users. J Hepatol 1995; 22:691-695
26. Chan SW, McOmish F, Holmes EC, et al: Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol 1992; 73(pt5):1131-1141
27. Yamada M, Kakumu S, Yoshioka K, et al: Hepatitis C virus genotypes are not responsible for development of serious liver disease. Dig Dis Sci 1994; 39: 234-239
28. Lau JYN, Davis GL, Kniffen J, et al: Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341:1501-1504 [erratum published in Lancet 1993; 342:504]
29. Gordon SC, Kodali VP, Silverman AL, et al: Levels of hepatitis C virus RNA and liver histology in chronic type C hepatitis. Am J Gastroenterol 1994; 89:1458-1461
30. Poynard T, Aubert A, Lazizi Y, et al: Is hepatitis C virus infection a cause of cirrhosis among drinkers? In Hollinger FB, Lemon SM, Margolis HS (Eds): Viral Hepatitis and Liver Disease - International Symposium on Viral Hepatitis and Liver Disease: Contemporary Issues and Future Prospects. Baltimore, Md, Williams & Wilkins, 1990, pp 681-683
31. Laurent-Puig P, Dussaix E, Lecoz Y, Martes P, Buffet C: Prevalence of anti-hepatitis C virus antibodies among patients with alcoholic liver disease, supplemented by 4-RIBA (Letter). Dig Dis Sci 1992; 37:156-157
32. Zarski JP, Thelu MA, Moulin C, Rachail M, Seigneurin JM: Interest of the detection of hepatitis C virus RNA in patients with alcoholic liver disease. J Hepatol 1993; 17:10-14